Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy-Reference-Cited by-同舟云学术

Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy

Published:2023-09 Issue:5 Volume:9 Page:734-741
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Hahn Andrew W.,Kotecha Ritesh R.,Viscuse Paul V.,Pieretti Alberto C.,Wiele Andrew J.,Jonasch Eric,Lee Chung-Han,Gao Jianjun,Zurita Amado J.,Shah Amishi Y.,Campbell Matthew T.,Sharma Padmanee,Motzer Robert J.,Russo Paul,Wood Christopher G.,Tannir Nizar M.,Voss Martin H.,Karam Jose A.,Hakimi A. Ari,Msaouel Pavlos

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Sarcomatoid renal cell carcinoma: biology, natural history and management;Blum;Nat Rev Urol,2020

2. Renal cell carcinoma with rhabdoid features;Gökden;Am J Surg Pathol,2000

3. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma;Mian;J Urol,2002

4. Sarcomatoid renal cell carcinoma: population-based study of 879 patients;Alevizakos;Clin Genitourin Cancer,2019

5. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters;Delahunt;Am J Surg Pathol,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de‐differentiation (ARON‐1 study);International Journal of Cancer;2024-09-07

2. Best practices and recommendations for grossing and reporting of post-immunotherapy nephrectomy specimens: a single-institution experience of 70 cases;Diagnostic Histopathology;2024-05

3. Head-to-head comparisons of enhanced CT, 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in identifying adverse pathology of clear-cell renal cell carcinoma: a prospective study;International braz j urol;2023-12

4. The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma;Cancers;2023-07-29